{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "VALCHLOR",
      "indication": "1 INDICATIONS AND USAGE VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy. VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy ( 1 ).",
      "manufacturer": "Helsinn Therapeutics (U.S.), Inc.",
      "splSetId": "6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57"
    }
  ],
  "id": "Mechlorethamine",
  "nciThesaurus": {
    "casRegistry": "51-75-2",
    "chebiId": "CHEBI:28925",
    "chemicalFormula": "C5H11Cl2N",
    "definition": "A synthetic agent related to sulphur mustard with antineoplastic and immunosuppressive properties. Nitrogen mustard (a member of a family of chemotherapy agents including cyclophosphamide and chlorambucil) is an irritant and carcinogenic agent metabolized to a highly reactive ethylene immonium derivative; the ethylene immonium derivative alkylates DNA and inhibits DNA replication. This agent also exhibits lympholytic properties.",
    "fdaUniiCode": "50D9XSG0VR",
    "identifier": "C62056",
    "preferredName": "Mechlorethamine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C697"
    ],
    "synonyms": [
      "Bis(2-chloroethyl)methylamine",
      "Chlorethazine",
      "Chlormethine",
      "HN 2",
      "HN2",
      "MECHLORETHAMINE",
      "Mechlorethamine",
      "Methylbis(beta-chloroethyl)amine",
      "Mustard",
      "Mustine",
      "NITROGEN MUSTARD HN-2",
      "Nitrogen Mustard",
      "chlorethazine",
      "chloromethine",
      "ethanamine,2-chloro-N-(2-chloroethyl)-N-methyl",
      "methylchlorethamine"
    ]
  }
}